Becton Dickinson
BDX
$230.48
Share price
-1.43%
Change (1 day)
-12.04%
Change (1 year)
Categories
Becton Dickinson, also known as BD, is one of the largest international medical technology companies that develops, produces and sells disposable medical devices, device systems and reagents. BD supplies hospitals, health care facilities, life scientists, clinical laboratories and the pharmaceutical industry.
Becton Dickinson (BDX) - Total debt
Total debt on the balance sheet as of December 2023 : $16.11 B
According to Becton Dickinson's latest financial reports the company's total debt is $16.11 B. A company’s total debt is the sum of all current and non-current debts.
Becton Dickinson - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-09-30 | $15.87 B | -1.16% |
| 2022-09-30 | $16.06 B | -8.77% |
| 2021-09-30 | $17.61 B | -1.78% |
| 2020-09-30 | $17.93 B | -7.53% |
| 2019-09-30 | $19.39 B | -9.79% |
| 2018-09-30 | $21.49 B | 13.91% |
| 2017-09-30 | $18.87 B | 63.36% |
| 2016-09-30 | $11.55 B | -9.91% |
| 2015-09-30 | $12.82 B | 222.89% |
| 2014-09-30 | $3.97 B | 0.03% |
| 2013-09-30 | $3.97 B | -4.7% |
| 2012-09-30 | $4.16 B | 53.18% |
| 2011-09-30 | $2.71 B | 60.15% |
| 2010-09-30 | $1.69 B | -10.22% |
| 2009-09-30 | $1.89 B | 63.83% |
| 2008-09-30 | $1.15 B | -0.76% |
| 2007-09-30 | $1.16 B | -15.95% |
| 2006-09-30 | $1.38 B | 9.22% |
| 2005-09-30 | $1.26 B | 3.81% |
| 2004-09-30 | $1.22 B | -6.52% |
| 2003-09-30 | $1.30 B | 5.52% |
| 2002-09-30 | $1.23 B | 0.05% |
| 2001-09-30 | $1.23 B |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $34.91 B | 116.74% | 🇺🇸 USA |
 Baxter BAX | $14.36 B | -10.84% | 🇺🇸 USA |
 Hologic HOLX | $2.57 B | -84.00% | 🇺🇸 USA |
 ResMed RMD | $1.39 B | -91.36% | 🇺🇸 USA |
 Teleflex TFX | $1.92 B | -88.04% | 🇺🇸 USA |
 Dentsply Sirona
XRAY | $2.29 B | -85.73% | 🇺🇸 USA |
 Intuitive Surgical ISRG | $87 M | -99.46% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $1.40 B | -91.28% | 🇺🇸 USA |